Effect of cycloheximide on epidermal growth factor receptor trafficking and signaling.

FEBS Lett

Dept. of Immunology, Institute for Cancer Research, Oslo University Hospital HF, Montebello, Oslo, Norway.

Published: October 2012

Cycloheximide is the most common protein synthesis inhibitor, and is believed to specifically inhibit the cytoplasmic protein synthesis. Here we demonstrate that cycloheximide induces internalization and redistribution of EGF receptor to early endosomes in HeLa cells independent of receptor tyrosine phosphorylation, but dependent on p38 MAPK activity. Degradation of EGF receptor or its downstream effectors was not observed. EGF-induced activation of ERK1/2 was inhibited upon pre-treatment with cycloheximide, but did not activate JNK. The observed effects of treatment with cycloheximide alone are significant and therefore results involving the use of cycloheximide for inhibition of protein synthesis must be interpreted with caution.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.febslet.2012.08.022DOI Listing

Publication Analysis

Top Keywords

protein synthesis
12
egf receptor
8
cycloheximide
6
cycloheximide epidermal
4
epidermal growth
4
growth factor
4
receptor
4
factor receptor
4
receptor trafficking
4
trafficking signaling
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!